NEURO-SELIRON 300MG CAP contains Pregabalin 300 mg, a next-generation antiepileptic and neuro-modulating agent that works by binding to the alpha-2-delta subunit of voltage-gated calcium channels in the central nervous system. By doing so, it effectively reduces the release of excitatory neurotransmitters like glutamate, noradrenaline, and substance P, thereby alleviating chronic pain, dampening anxiety symptoms, and stabilizing nerve excitability.

This formulation is primarily indicated for the management of neuropathic pain, including diabetic peripheral neuropathy, post-herpetic neuralgia, spinal cord injury-related nerve pain, and fibromyalgia. In addition to pain control, NEURO-SELIRON 300MG CAP is also used as adjunctive therapy in the treatment of partial-onset seizures in adults with epilepsy. It has demonstrated significant efficacy in improving sleep quality and reducing anxiety in patients suffering from chronic pain syndromes.

NEURO-SELIRON 300MG CAP offers a higher dosage strength, ideal for patients who require strong nerve pain suppression and who have already been titrated from lower dosages like 75 mg or 150 mg. The 300 mg strength allows for sustained plasma levels and extended therapeutic relief in individuals with moderate to severe nerve pain. Patients often report improved sleep, reduced burning or tingling sensations, and an overall better quality of life during regular use of this capsule.

Manufactured by Bluepill Express, NEURO-SELIRON 300MG CAP is processed in state-of-the-art WHO-GMP, ISO, and FDA-certified facilities, ensuring the highest pharmaceutical manufacturing standards. From sourcing raw Pregabalin API to encapsulation and packaging, every stage of production adheres to stringent quality control protocols, ensuring the consistency, purity, and safety of each capsule. The encapsulated form provides better gastrointestinal tolerability and patient compliance, especially for long-term regimens.

Bluepill Express supports third-party manufacturing and private labeling services for NEURO-SELIRON 300MG CAP, with flexible options in packaging and branding tailored to client requirements. Available in aluminum-aluminum or PVC blister strips, the product is typically packed in 10-capsule strips, with labeling conforming to domestic or international regulatory standards. We cater to partners across India, Asia, Africa, CIS countries, and Latin America, providing assistance with export documentation, product registration, and pharmacovigilance.

NEURO-SELIRON 300MG CAP is typically prescribed once or twice daily, depending on the clinical response and patient tolerance. Titration should be done cautiously to minimize side effects like dizziness, somnolence, or peripheral edema. The high-dose format suits patients already acclimatized to Pregabalin and needing sustained neurological relief. The product is not habit-forming but should be discontinued gradually to avoid withdrawal effects.

In clinical settings, NEURO-SELIRON 300MG CAP has become a reliable choice among neurologists, diabetologists, pain physicians, psychiatrists, and general practitioners aiming to offer evidence-based, long-term solutions to patients suffering from chronic neuropathic conditions.